Viewing Study NCT05763459


Ignite Creation Date: 2025-12-24 @ 3:04 PM
Ignite Modification Date: 2026-01-04 @ 5:13 PM
Study NCT ID: NCT05763459
Status: COMPLETED
Last Update Posted: 2023-06-26
First Post: 2023-02-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Study of ABBV-CLS-7262, Rosuvastatin, and Digoxin in Healthy Subjects
Sponsor: Calico Life Sciences LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Digoxin View
None Rosuvastatin View
None Molecular Mechanisms of Pharmacological Action View
None Physiological effects of drugs View